(c) 2024 PillSync.com

21 Ethinyl Estradiol 0.03 MG Levonorgestrel 0.15 MG Oral Tablet 7 Inert Ingredients 1 MG Oral Tablet Pack Marlissa 28 Day

INDICATIONS AND USAGE MARLISSA ® (levonorgestrel and ethinyl estradiol tablets) is indicated for use by females of reproductive potential to prevent pregnancy.

glenmark pharmaceuticals inc., usa


3 years ago ROUND ORANGE A5 21 Ethinyl Estradiol 0.03 MG  Levonorgestrel 0.15 MG Oral Tablet  7 Inert Ingredients 1 MG Oral Tablet  Pack Marlissa 28 Day

ROUND ORANGE A5

HOW SUPPLIED/ STORAGE AND HANDLING MARLISSA ® (

LEVONORGESTREL AND ETHINYL ESTRADIOL tablets, USP 0.15 mg/0.03 mg) is available in carton of 3 blisters, each containing 28 tablets (NDC 68462-388-29): Each blister contains: 21 Active Tablets: Light orange to orange color, round, biconvex, uncoated tablets with ‘A5’ debossed on one side. 7 Inert Tablets: Light pink to pink color, round, biconvex, uncoated tablets with ‘A6’ debossed on one side. Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light. Manufactured by: Glenmark Pharmaceuticals Limited Colvale-Bardez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 Questions? 1 (888) 721-7115 www.glenmarkpharma-us.com June 2022 logo.jpg


More pills like ROUND A5












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site